Literature DB >> 21660463

ARF triggers cell G1 arrest by a P53 independent ERK pathway.

Hansong Du1, Weiqi Yao, Min Fang, Dongcheng Wu.   

Abstract

In this study, in order to investigate the p53-independent function of p14ARF, we established p14ARF-inducible clones in the p53-deficient HCT cell line using the doxycycline-inducible expression system. A strong cell growth inhibition and G1/S arrest were observed after doxycycline induction in p53-/-HCT cells, and the cells also exhibited an obvious decrease of DNA synthesis. We further examined if the MEK/ERK pathway is involved in the G1 arrest induced by p14ARF in p53-/-HCT cells. The results indicate that ERK1/2 and p21 were activated upon p14ARF induction. Totally, the functional roles of ERK and p21 for ARF in p53-independent tumor suppression were demonstrated.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21660463     DOI: 10.1007/s11010-011-0912-4

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.

Authors:  Koji Itahana; Krishna P Bhat; Aiwen Jin; Yoko Itahana; David Hawke; Ryuji Kobayashi; Yanping Zhang
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

2.  Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF.

Authors:  Abhishek Datta; Alo Nag; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

3.  P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis.

Authors:  Jeong A Han; Jong-Il Kim; Pat P Ongusaha; Daniel H Hwang; Leslie R Ballou; Alka Mahale; Stuart A Aaronson; Sam W Lee
Journal:  EMBO J       Date:  2002-11-01       Impact factor: 11.598

4.  Tumor spectrum in ARF-deficient mice.

Authors:  T Kamijo; S Bodner; E van de Kamp; D H Randle; C J Sherr
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

Review 5.  p53 induced growth arrest versus apoptosis and its modulation by survival cytokines.

Authors:  Dan A Liebermann; Barbara Hoffman; Diana Vesely
Journal:  Cell Cycle       Date:  2007-01-29       Impact factor: 4.534

6.  p14ARF triggers G2 arrest through ERK-mediated Cdc25C phosphorylation, ubiquitination and proteasomal degradation.

Authors:  Beatrice Eymin; Paule Claverie; Caroline Salon; Christian Brambilla; Elisabeth Brambilla; Sylvie Gazzeri
Journal:  Cell Cycle       Date:  2006-04-01       Impact factor: 4.534

7.  ATM activity contributes to the tumor-suppressing functions of p14ARF.

Authors:  Yanxia Li; Dongcheng Wu; Biao Chen; Alistair Ingram; Lizhi He; Lieqi Liu; Dahai Zhu; Anil Kapoor; Damu Tang
Journal:  Oncogene       Date:  2004-09-23       Impact factor: 9.867

Review 8.  How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

Authors:  Yohannes Mebratu; Yohannes Tesfaigzi
Journal:  Cell Cycle       Date:  2009-04-11       Impact factor: 4.534

9.  An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis.

Authors:  R C Kovi; S Paliwal; S Pande; S R Grossman
Journal:  Cell Death Differ       Date:  2009-10-02       Impact factor: 15.828

10.  Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.

Authors:  Lynette Moore; Sundaresan Venkatachalam; Hannes Vogel; Julie C Watt; Chao-Ling Wu; Heather Steinman; Stephen N Jones; Lawrence A Donehower
Journal:  Oncogene       Date:  2003-10-30       Impact factor: 9.867

View more
  1 in total

1.  Bone marrow-derived mesenchymal stem cells protect against cisplatin-induced acute kidney injury in rats by inhibiting cell apoptosis.

Authors:  Shaohua Qi; Dongcheng Wu
Journal:  Int J Mol Med       Date:  2013-10-08       Impact factor: 4.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.